In radioligand therapy, tumor growth was notably suppressed in the PEI + 0.45 mCi 177Lu-DOTA-tTF and PEI + 0.75 mCi 177Lu-DOTA-tTF groups compared to the PEI alone group (Figure 6). The gene discussed is RHOH; the disease is neoplasm.